Harrow Health Inc. 8.625%... (HROWL)
Harrow Health 8.625% Senior Notes due 2026 Statistics
Share Statistics
Harrow Health 8.625% Senior Notes due 2026 has 43.5M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 43.5M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 43 |
| FTD / Avg. Volume | 0.56% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is null. Harrow Health 8.625% Senior Notes due 2026's PEG ratio is undefined.
| PE Ratio | undefined |
| Forward PE | n/a |
| PS Ratio | 2.81 |
| Forward PS | null |
| PB Ratio | 5.16 |
| P/FCF Ratio | undefined |
| PEG Ratio | undefined |
Enterprise Valuation
Harrow Health 8.625% Senior Notes due 2026 has an Enterprise Value (EV) of 481.72M.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of undefined.
| Current Ratio | 2.83 |
| Quick Ratio | 2.61 |
| Debt / Equity | undefined |
| Debt / EBITDA | - |
| Debt / FCF | - |
| Interest Coverage | undefined |
Financial Efficiency
Return on Equity is -0.34% and Return on Invested Capital is 0.17%.
| Return on Equity | -0.34% |
| Return on Assets | -0.08% |
| Return on Invested Capital | 0.17% |
| Revenue Per Employee | $599.97K |
| Profits Per Employee | $-112.49K |
| Employee Count | 217 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.65 |
Taxes
| Income Tax | 701K |
| Effective Tax Rate | -0.03% |
Stock Price Statistics
The stock price has increased by 3.82% in the last 52 weeks. The beta is 0.14, so Harrow Health 8.625% Senior Notes due 2026's price volatility has been higher than the market average.
| Beta | 0.14 |
| 52-Week Price Change | 3.82% |
| 50-Day Moving Average | 25.3 |
| 200-Day Moving Average | 25.25 |
| Relative Strength Index (RSI) | 51.64 |
| Average Volume (20 Days) | 7.61K |
Income Statement
In the last 12 months, Harrow Health 8.625% Senior Notes due 2026 had revenue of 130.19M and earned -24.41M in profits. Earnings per share was -0.75.
| Revenue | 130.19M |
| Gross Profit | 90.55M |
| Operating Income | 431K |
| Net Income | -24.41M |
| EBITDA | 9.72M |
| EBIT | 431K |
| Earnings Per Share (EPS) | -0.75 |
Balance Sheet
The company has 74.08M in cash and 190.5M in debt, giving a net cash position of -116.42M.
| Cash & Cash Equivalents | 74.08M |
| Total Debt | 190.5M |
| Net Cash | -116.42M |
| Retained Earnings | -133.9M |
| Total Assets | 351.54M |
| Working Capital | 52.06M |
Cash Flow
In the last 12 months, operating cash flow was 3.84M and capital expenditures -152.55M, giving a free cash flow of -148.71M.
| Operating Cash Flow | 3.84M |
| Capital Expenditures | -152.55M |
| Free Cash Flow | -148.71M |
| FCF Per Share | -4.56 |
Margins
Gross margin is 69.55%, with operating and profit margins of 0.33% and -18.75%.
| Gross Margin | 69.55% |
| Operating Margin | 0.33% |
| Pretax Margin | -18.21% |
| Profit Margin | -18.75% |
| EBITDA Margin | 7.47% |
| EBIT Margin | 0.33% |
| FCF Margin | -114.23% |
Dividends & Yields
HROWL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.96% |
| FCF Yield | -13.51% |
Analyst Forecast
Currently there are no analyst rating for HROWL.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.14 |
| Piotroski F-Score | 4 |